Drug Safety Newsletter 47th Edition
19 April 2012
Topics covered in this edition of the newsletter include:
- Aliskiren - New contraindications and warnings due to risks of cardiovascular and renal adverse reactions (brands include, Rasilez, Rasilez HCT, Rasilamlo)
- Proton pump inhibitors - Small increased risk of bone fractures with long term use in patients with risk factors
- Oral Methotrexate - Risk of unintentional overdose due to medication errors
- Miconazole oral gel (Daktarin oral gel) - Interaction with warfarin
- Children's liquid paracetamol medicines - New dosage instructions
Drug Safety Newsletter 47th Edition